D. Mo

发表

Changing patterns of the adult growth hormone deficiency diagnosis documented in a decade-long global surveillance database.

S. Melmed, C. Strasburger, W. Blum, 2009, The Journal of clinical endocrinology and metabolism.

Radiographic Progression of Structural Joint Damage Over 5 Years of Baricitinib Treatment in Patients With Rheumatoid Arthritis: Results From RA-BEYOND

Yoshiya Tanaka, P. Durez, S. Beattie, 2021, The Journal of Rheumatology.

Pain Reduction in Rheumatoid Arthritis Patients Who Use Opioids: A Post Hoc Analysis of Phase 3 Trials of Baricitinib

P. Taylor, L. Simon, J. Pope, 2021, ACR open rheumatology.

Breast cancer trends in Manitoba: 40 years of follow-up.

E. Kliewer, D. Turner, A. Demers, 2005, Chronic diseases in Canada.

Prevalence of metabolic syndrome in adult hypopituitary growth hormone (GH)-deficient patients before and after GH replacement.

P. Chanson, D. Kleinberg, E. Erfurth, 2011, The Journal of clinical endocrinology and metabolism.

Prevalence and incidence of diabetes mellitus in adult patients on growth hormone replacement for growth hormone deficiency: a surveillance database analysis.

P. Chanson, R. Bouillon, S. Lamberts, 2011, The Journal of clinical endocrinology and metabolism.

Associations between traits (blood pressure and body height growth) and reproductive timing related genetic variants from genome-wide association studies

D. Mo, 2017 .

Fracture risk in adult patients treated with growth hormone replacement therapy for growth hormone deficiency: a prospective observational cohort study.

M. Fleseriu, R. Bouillon, N. Jia, 2015, The lancet. Diabetes & endocrinology.

Ten-year change in quality of life in adults on growth hormone replacement for growth hormone deficiency: an analysis of the hypopituitary control and complications study.

C. Strasburger, W. Blum, S. Webb, 2014, The Journal of clinical endocrinology and metabolism.

Obesity and glycemic control in patients with diabetes mellitus: Analysis of physician electronic health records in the US from 2009-2011.

B. Hoogwerf, J. Bae, M. Lage, 2016, Journal of diabetes and its complications.

Adult mortality or morbidity is not increased in childhood-onset growth hormone deficient patients who received pediatric GH treatment: an analysis of the Hypopituitary Control and Complications Study (HypoCCS)

S. Melmed, E. Erfurth, D. Hardin, 2013, Pituitary.

Metabolic, cardiovascular, and cerebrovascular outcomes in growth hormone-deficient subjects with previous cushing's disease or non-functioning pituitary adenoma.

S. Melmed, W. Woodmansee, S. Lamberts, 2010, The Journal of clinical endocrinology and metabolism.

THU0078 SAFETY PROFILE OF BARICITINIB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS UP TO 7 YEARS: AN UPDATED INTEGRATED SAFETY ANALYSIS

M. Genovese, G. Burmester, J. Smolen, 2019, Poster Presentations.

Safety profile of baricitinib for the treatment of rheumatoid arthritis over a median of 3 years of treatment: an updated integrated safety analysis

M. Genovese, G. Burmester, J. Smolen, 2020, The Lancet Rheumatology.

Prevalence of metabolic syndrome in adult hypopituitary growth hormone (GH)-deficient patients before and after GH replacement.

P. Chanson, D. Kleinberg, E. Erfurth, 2011, The Journal of clinical endocrinology and metabolism.

Changing patterns of the adult growth hormone deficiency diagnosis documented in a decade-long global surveillance database.

S. Melmed, C. Strasburger, W. Blum, 2009, The Journal of clinical endocrinology and metabolism.